Clinical trial
Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
NCT00361933 · University of Washington, Other · Withdrawn
Key facts
| NCT number | NCT00361933 |
|---|---|
| Title | Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease |
| Official title | Clinical and Virologic Response to HHV-8 Associated Multicentric Castleman's Disease to Valganciclovir |
| Lead sponsor | University of Washington, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Giant Lymph Node Hyperplasia |
| Intervention type | Drug |
| Interventions | Valganciclovir |
| Enrollment | 0 |
| Start date | Dec 1, 2008 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Aug 9, 2006 |
| Last update posted | Apr 18, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: